DXC Technology Co (DXC)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 03-31. Amounts in USD.

Revenue Quarterly

0 2B 4B 6B Q3 '17: 1.9B Q4 '17: 4.1B Q4 '17: 1.9B Q1 '18: 5.2B Q2 '18: 5.5B Q3 '18: 5.5B Q4 '18: 5.6B Q1 '19: 5.3B Q2 '19: 5B Q3 '19: 5.2B Q4 '19: 5.3B Q1 '20: 4.9B Q2 '20: 4.9B Q3 '20: 5B Q4 '20: 4.8B Q1 '21: 4.5B Q2 '21: 4.6B Q3 '21: 4.3B Q4 '21: 4.4B Q1 '22: 4.1B Q2 '22: 4B Q3 '22: 4.1B Q4 '22: 4B Q1 '23: 3.7B Q2 '23: 3.6B Q3 '23: 3.6B Q4 '23: 3.6B Q1 '24: 3.4B Q2 '24: 3.4B Q3 '24: 3.4B Q4 '24: 3.4B Q1 '25: 3.2B Q2 '25: 3.2B Q3 '25: 3.2B Q4 '25: 3.2B Q1 '26: 3.2B Q2 '26: 3.2B Q3 '26: 3.2B Q4 '26: 3.1B Q1 '27: 3B Q2 '18 Q3 '19 Q4 '20 Q1 '22 Q2 '23 Q3 '24 Q4 '25 Q1 '27

Gross Profit Quarterly

0 350M 700M 1.1B Q1 '19: 906M Q2 '19: 1B Q3 '19: 941M Q4 '19: 935M Q1 '20: 794M Q2 '20: 700M Q3 '20: 711M Q4 '20: 511M Q1 '21: 377M Q2 '21: 462M Q3 '21: 474M Q4 '21: 342M Q1 '22: 459M Q2 '22: 487M Q3 '22: 480M Q4 '22: 414M Q1 '23: 379M Q2 '23: 403M Q3 '23: 384M Q4 '23: 467M Q1 '24: 376M Q2 '24: 435M Q3 '24: 406M Q4 '24: 441M Q1 '25: 377M Q2 '25: 479M Q3 '25: 482M Q4 '25: 450M Q1 '26: 462M Q2 '26: 476M Q3 '26: 471M Q4 '26: 440M Q1 '27: 340M Q3 '19 Q4 '20 Q1 '22 Q2 '23 Q3 '24 Q4 '25 Q1 '27

Revenue minus cost of sales. This filer tags no gross profit of its own..

Operating Income Quarterly

-300M 0 300M 600M 900M Q3 '17: 176M Q4 '17: -30M Q4 '17: 216M Q1 '18: 570M Q2 '18: 740M Q3 '18: 797M Q4 '18: 882M Q1 '19: 803M Q2 '19: 799M Q3 '19: 840M Q4 '19: 827M Q1 '20: 652M Q2 '20: 529M Q3 '20: 528M Q4 '20: 352M Q1 '21: 190M Q2 '21: 283M Q3 '21: 300M Q4 '21: 329M Q1 '22: 332M Q2 '22: 346M Q3 '22: 355M Q4 '22: 342M Q1 '23: 259M Q2 '23: 269M Q3 '23: 309M Q4 '23: 299M Q1 '24: 224M Q2 '24: 251M Q3 '24: 256M Q4 '24: 284M Q1 '25: 224M Q2 '25: 279M Q3 '25: 286M Q4 '25: 230M Q1 '26: 216M Q2 '26: 254M Q3 '26: 263M Q4 '26: 237M Q1 '27: 150M Q2 '18 Q3 '19 Q4 '20 Q1 '22 Q2 '23 Q3 '24 Q4 '25 Q1 '27

Net Income Quarterly

-4.5B -3B -1.5B 0 1.5B 3B 4.5B Q2 '17: -21M Q2 '17: 15M Q3 '17: 31M Q4 '17: -37M Q4 '17: -148M Q1 '18: 159M Q2 '18: 256M Q3 '18: 776M Q4 '18: 560M Q1 '19: 259M Q2 '19: 262M Q3 '19: 462M Q4 '19: 274M Q1 '20: 163M Q2 '20: -2.1B Q3 '20: 82M Q4 '20: -3.5B Q1 '21: -205M Q2 '21: -244M Q3 '21: 1.1B Q4 '21: -798M Q1 '22: 278M Q2 '22: -188M Q3 '22: 98M Q4 '22: 530M Q1 '23: 102M Q2 '23: 27M Q3 '23: 59M Q4 '23: -756M Q1 '24: 36M Q2 '24: 99M Q3 '24: 156M Q1 '25: 26M Q2 '25: 42M Q3 '25: 57M Q4 '25: 264M Q1 '26: 16M Q2 '26: 36M Q3 '26: 107M Q1 '27: 122M Q4 '17 Q1 '19 Q2 '20 Q3 '21 Q4 '22 Q1 '24 Q3 '25 Q1 '27

Cost of Revenue Quarterly

0 1.5B 3B 4.5B Q4 '16: 4B Q4 '17: 3.6B Q1 '19: 3.9B Q2 '19: 3.5B Q3 '19: 3.7B Q4 '19: 3.8B Q1 '20: 3.6B Q2 '20: 3.7B Q3 '20: 3.8B Q4 '20: 3.8B Q1 '21: 3.6B Q2 '21: 3.6B Q3 '21: 3.3B Q4 '21: 3.6B Q1 '22: 3.3B Q2 '22: 3.1B Q3 '22: 3.2B Q4 '22: 3.2B Q1 '23: 2.9B Q2 '23: 2.8B Q3 '23: 2.8B Q4 '23: 2.7B Q1 '24: 2.7B Q2 '24: 2.6B Q3 '24: 2.6B Q4 '24: 2.6B Q1 '25: 2.5B Q2 '25: 2.4B Q3 '25: 2.4B Q4 '25: 2.4B Q1 '26: 2.4B Q2 '26: 2.4B Q3 '26: 2.4B Q4 '26: 2.4B Q1 '27: 2.4B Q3 '19 Q4 '20 Q1 '22 Q2 '23 Q3 '24 Q4 '25 Q1 '27

Operating Cash Flow Quarterly

-2.1B -1.4B -700M 0 700M 1.4B 2.1B Q2 '17: 192M Q3 '17: 563M Q4 '17: -1.9B Q1 '18: 379M Q2 '18: 825M Q3 '18: 806M Q4 '18: 557M Q1 '19: 369M Q2 '19: 480M Q3 '19: 186M Q4 '19: 748M Q1 '20: -66M Q2 '20: 1.7B Q3 '20: 477M Q4 '20: 288M Q1 '21: 119M Q2 '21: 472M Q3 '21: -187M Q4 '21: -280M Q1 '22: -29M Q2 '22: 563M Q3 '22: 696M Q4 '22: 271M Q1 '23: 163M Q2 '23: 212M Q3 '23: 625M Q4 '23: 415M Q1 '24: 127M Q2 '24: 248M Q3 '24: 706M Q4 '24: 280M Q1 '25: 238M Q2 '25: 195M Q3 '25: 650M Q4 '25: 315M Q1 '26: 186M Q2 '26: 409M Q3 '26: 414M Q4 '26: 239M Q1 '27: 418M Q2 '18 Q3 '19 Q4 '20 Q1 '22 Q2 '23 Q3 '24 Q4 '25 Q1 '27

Free Cash Flow Quarterly

-2.1B -1.4B -700M 0 700M 1.4B 2.1B Q2 '17: 107M Q3 '17: 507M Q4 '17: -2B Q1 '18: 310M Q2 '18: 771M Q3 '18: 754M Q4 '18: 508M Q1 '19: 290M Q2 '19: 426M Q3 '19: 100M Q4 '19: 670M Q1 '20: -171M Q2 '20: 1.6B Q3 '20: 429M Q4 '20: 178M Q1 '21: 24M Q2 '21: 411M Q3 '21: -246M Q4 '21: -326M Q1 '22: -127M Q2 '22: 496M Q3 '22: 644M Q4 '22: 234M Q1 '23: 95M Q2 '23: 134M Q3 '23: 559M Q4 '23: 360M Q1 '24: 72M Q2 '24: 195M Q3 '24: 670M Q4 '24: 242M Q1 '25: 190M Q2 '25: 154M Q3 '25: 568M Q4 '25: 238M Q1 '26: 143M Q2 '26: 365M Q3 '26: 359M Q4 '26: 169M Q1 '27: 359M Q2 '18 Q3 '19 Q4 '20 Q1 '22 Q2 '23 Q3 '24 Q4 '25 Q1 '27

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 100M 200M 300M Q2 '17: 139M Q2 '17: 143.8M Q3 '17: 144.8M Q1 '18: 289.5M Q2 '18: 289.3M Q3 '18: 289.8M Q1 '19: 289.3M Q2 '19: 285.8M Q3 '19: 279M Q1 '20: 269M Q2 '20: 258.7M Q3 '20: 256.1M Q1 '21: 253.6M Q2 '21: 254.1M Q3 '21: 255.8M Q1 '22: 260.3M Q2 '22: 252.4M Q3 '22: 254.8M Q1 '23: 237.4M Q2 '23: 233.2M Q3 '23: 233M Q1 '24: 213.8M Q2 '24: 203.1M Q3 '24: 191.9M Q1 '25: 182.9M Q2 '25: 183.9M Q3 '25: 184.8M Q1 '26: 185M Q2 '26: 179.2M Q3 '26: 175.8M Q1 '27: 166.3M Q3 '17 Q1 '19 Q2 '20 Q3 '21 Q1 '23 Q2 '24 Q3 '25 Q1 '27

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-24.00 -16.00 -8.00 0.00 8.00 16.00 24.00 Q4 '17: -0.89 Q1 '18: -0.19 Q2 '18: 0.59 Q3 '18: 3.06 Q4 '18: 6.04 Q1 '19: 6.39 Q2 '19: 6.43 Q3 '19: 5.41 Q4 '19: 4.50 Q1 '20: 4.21 Q2 '20: -4.90 Q3 '20: -6.24 Q4 '20: -20.82 Q1 '21: -22.24 Q2 '21: -15.01 Q3 '21: -11.04 Q4 '21: -0.59 Q1 '22: 1.29 Q2 '22: 1.51 Q3 '22: -2.40 Q4 '22: 2.79 Q1 '23: 2.15 Q2 '23: 3.01 Q3 '23: 2.88 Q4 '23: -2.48 Q1 '24: -2.74 Q2 '24: -2.37 Q3 '24: -1.81 Q4 '25: 2.10 Q1 '26: 2.05 Q2 '26: 2.02 Q3 '26: 2.32 Q3 '18 Q3 '19 Q3 '20 Q3 '21 Q3 '22 Q3 '23 Q3 '24 Q3 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.